Time lines of infection and disease in human influenza: a review of volunteer challenge studies.

By F. Carrat, E. Vergu, Neil M. Ferguson, M. Lemaitre, Simon Cauchemez, S. Leach, A. Valleron. American Journal of Epidemiology, 2008

1,154 citations recorded by the source corpus.

The dynamics of viral shedding and symptoms following influenza virus infection are key factors when considering epidemic control measures. The authors reviewed published studies describing the course of influenza virus infection in placebo-treated and untreated volunteers challenged with wild-type influenza virus. A total of 56 different studies with 1,280 healthy participants were considered. Viral shedding increased sharply between 0.5 and 1 day after challenge and consistently peaked on day 2. The duration of viral shedding averaged over 375 participants was 4.80 days (95% confidence interval: 4.31, 5.29). The frequency of symptomatic infection was 66.9% (95% confidence interval: 58.3, 74.5). Fever was observed in 37.0% of A/H1N1, 40.6% of A/H3N2 (p = 0.86), and 7.5% of B infections (p = 0.001). The total symptoms scores increased on day 1 and peaked on day 3. Systemic symptoms peaked on day 2. No such data exist for children or elderly subjects, but epidemiologic studies suggest that the natural history might differ. The present analysis confirms prior expert opinion on the duration of viral shedding or the frequency of asymptomatic influenza infection, extends prior knowledge on the dynamics of viral shedding and symptoms, and provides original results on the frequency of respiratory symptoms or fever.

Subfields: Epidemiology, Modeling and Simulation

View Paper: https://www.semanticscholar.org/paper/9c7a44713676a48ef14d125ccf6f27d98bfc9817

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Modeling and Simulation

Citations in the corpus

Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) (2020, methodology): “2%) were considered 35 symptomatic upon arrival based on (1) temperature screening before disembarkation, 36 and (2) face-to-face interviews eliciting information on symptoms including fever, 37 cough, and other non-specific symptoms consistent with COVID-19.”
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). (2011, background): “Adults can shed influenza virus from the day before symptoms begin through 5–10 days after illness onset (39,40).”
Modeling the spatial spread of infectious diseases: the GLobal Epidemic and Mobility computational model (2010, result): “The average generation interval for our choice is around 4 days, a value close to published estimates for the A/H3N2 [5].”
FluTE, a Publicly Available Stochastic Influenza Epidemic Simulation Model (2010, background): “After incubation, the individual has a 67% chance of becoming symptomatic [14,15].”
The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks (2012, background): “6 days and standard deviation 1 day [17].”
Critically Ill patients with 2009 influenza A(H1N1) in Mexico. (2009, neutral): “BMI, median (IQR)b 28 (25-32) 32 (25-42) .”
Modelling transmission and control of the COVID-19 pandemic in Australia (2020, background): “Despite several similarities with influenza, COVID-19 has a number of notable differences, specifically in relation to transmissions across children, its reproductive number R 0 , incubation and generation periods, proportion of symptomatic to asymptomatic cases [28, 29, 30] , the infectivity of the”